Vaccine 4 1 1 for 6-30-2020 - tracking the race to find a cure for the Coronavirus - Covid 19

On this episode of Vaccine 411… a vaccine that would not only prevent COVID-19, but could also treat active infections. Sign us up!

First, the latest vaccine news from around the world: 

Brazil: Federal regulator approval is expected this week for Phase III trials of Sinovac’s Coronavac vaccine to begin. 9,000 volunteers have already been registered reports U.S. News and World Report. Brazil also signed an agreement to produce Oxford University/AstraZeneca’s vaccine candidate. 

China:  CanSino Biologics vaccine was approved for limited use within the Chinese military. The company published Phase I data in May, Phase II data has yet to be published. Citing competitive reasons, the company would not say if the vaccine would be mandatory for all service members. 

United States: Gilead Sciences, the maker of Remdesivir, will typically charge hospitals $3,120/patient for those with private insurance. Other developed countries will pay about 25% less per patient. The Trump Administration has secured half a million doses for U.S. hospitals.  

Hosted on Acast. See acast.com/privacy for more information.